Paper8100738
Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors.
Saito H and 9 others. Cancer Res, 1993. Cited by 196 papers, by iCite.
Cite this record
ConductScience Library. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors. Papers, record 8100738. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8100738
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Chromosome Deletion | Major topic |
| Chromosome Mapping | Major topic |
| Chromosomes, Human, Pair 17 | Major topic |
| Ovarian Neoplasms | Major topic |
| Adenocarcinoma | |
| Adenocarcinoma, Mucinous | |
| Female | |
| Genetic Markers | |
| Humans | |
| Menopause | |
| Polymorphism, Restriction Fragment Length |
Source PubMed
Cited by65
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 196 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39761421 | Structure-Activity Relationship Studies of an Autophagy Inhibitor That Targets the ATG14L-Beclin1 Protein-Protein Interaction Reveal Modifications That Improve Potency and Solubility and Maintain Selectivity. | J Med Chem | 2025 | https://conductscience.org/library/papers/39761421 | PubMed |
| 39403142 | The role of SIRT1 in autophagy and drug resistance: unveiling new targets and potential biomarkers in cancer therapy. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/39403142 | PubMed |
| 38045051 | Targeting autophagy and beyond: Deconvoluting the complexity of Beclin-1 from biological function to cancer therapy. | Acta Pharm Sin B | 2023 | https://conductscience.org/library/papers/38045051 | PubMed |
| 37251450 | Seeking a better understanding of the non-receptor tyrosine kinase, SRMS. | Heliyon | 2023 | https://conductscience.org/library/papers/37251450 | PubMed |
| 36614089 | Autophagy and Apoptosis: Current Challenges of Treatment and Drug Resistance in Multiple Myeloma. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36614089 | PubMed |
| 35760911 | Calorie restriction and breast cancer treatment: a mini-review. | J Mol Med (Berl) | 2022 | https://conductscience.org/library/papers/35760911 | PubMed |
| 34521293 | Beclin-1 is a novel predictive biomarker for canine cutaneous and subcutaneous mast cell tumors. | Vet Pathol | 2022 | https://conductscience.org/library/papers/34521293 | PubMed |
| 33953166 | SOX2 promotes chemoresistance, cancer stem cells properties, and epithelial-mesenchymal transition by β-catenin and Beclin1/autophagy signaling in colorectal cancer. | Cell Death Dis | 2021 | https://conductscience.org/library/papers/33953166 | PubMed |
| 33507706 | The Role of Vesicular Stomatitis Virus Matrix Protein in Autophagy in the Breast Cancer. | Asian Pac J Cancer Prev | 2021 | https://conductscience.org/library/papers/33507706 | PubMed |
| 33147747 | Pathogenic Single Nucleotide Polymorphisms on Autophagy-Related Genes. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33147747 | PubMed |
| 32114389 | Autophagy in endothelial cells regulates their haematopoiesis-supporting ability. | EBioMedicine | 2020 | https://conductscience.org/library/papers/32114389 | PubMed |
| 32102330 | Strategy of Hepatic Metabolic Defects Induced by beclin1 Heterozygosity in Adult Zebrafish. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32102330 | PubMed |
| 31995752 | EGFR Signaling Stimulates Autophagy to Regulate Stem Cell Maintenance and Lipid Homeostasis in the Drosophila Testis. | Cell Rep | 2020 | https://conductscience.org/library/papers/31995752 | PubMed |
| 31803616 | Insight Into the Role of Autophagy in Osteosarcoma and Its Therapeutic Implication. | Front Oncol | 2019 | https://conductscience.org/library/papers/31803616 | PubMed |
| 30727895 | Autophagy and Apoptosis Specific Knowledgebases-guided Systems Pharmacology Drug Research. | Curr Cancer Drug Targets | 2019 | https://conductscience.org/library/papers/30727895 | PubMed |
| 30302772 | The multifaceted role of autophagy in cancer and the microenvironment. | Med Res Rev | 2019 | https://conductscience.org/library/papers/30302772 | PubMed |
| 29405978 | New Insights Into Beclin-1: Evolution and Pan-Malignancy Inhibitor Activity. | Adv Cancer Res | 2018 | https://conductscience.org/library/papers/29405978 | PubMed |
| 28915706 | The role of autophagy in hepatocellular carcinoma: friend or foe. | Oncotarget | 2017 | https://conductscience.org/library/papers/28915706 | PubMed |
| 28536348 | Targeting Autophagy for Oncolytic Immunotherapy. | Biomedicines | 2017 | https://conductscience.org/library/papers/28536348 | PubMed |
| 28438385 | Small molecules inhibit STAT3 activation, autophagy, and cancer cell anchorage-independent growth. | Bioorg Med Chem | 2017 | https://conductscience.org/library/papers/28438385 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8100738
GET https://conductscience.org/api/papers/v1/8100738/cited_by?page=2